BioCentury
ARTICLE | Company News

TPP Global Development, University of Aberdeen deal

April 4, 2011 7:00 AM UTC

TPP partnered with the university to develop IP related to nervous system disorders, inflammatory diseases and cancer over five years. TPP said the IP is still in preclinical development. Further term...